Notified Bodies Warn Manufacturers And Decision-Makers Not To Sabotage MDR Implementation
Executive Summary
Manufacturers delaying their MDR transition could disrupt notified body planning and make a mockery of the whole sector’s efforts to achieve the extend timeline now in place for legacy products.
You may also be interested in...
Taking Steps Towards Improving Innovation Opportunities In The EU Regulatory Environment
The German notified body, TÜV SÜD, is looking to help create a more favorable regulatory environment for medtech innovation within the EU as the debate continues over damaging MDR/IVDR implementation practices.
MDR Amending Regulation Officially Published And Already In Force
The deadlines for legacy products under the Medical Device Regulation have changed. Here are the essentials that all medtech players need to understand in how the MDR has now been amended.
Commission Text Clarifying Timelines For Annex XVI Devices May Leave Companies Dazed
The revised timelines around products generally used for aesthetic purposes, a small subset of products falling under the Medical Device Regulation, create their own microsphere of complexity.